Recently, Lasso Biotechnology has triumphantly concluded its Series B financing round. This particular funding initiative was primarily steered by the Central Enterprise Rural Fund, with additional contributions from Centurium Capital and the Suzhou Agricultural Development Group. Moreover, SDIC Chuangyi has designated a director to become a member of Lasso Biotechnology's board of directors. Both SDIC Chuangyi and the Suzhou Agricultural Development Group have made strategic equity investments, offering both resource and financial backing. Centurium Capital, on its part, has further escalated its investment, aiding Lasso Biotechnology in its quest to emerge as a frontrunner in the solid-phase chip industry.

Established in Suzhou in 2018, Lasso Biotechnology holds the distinction of being the third enterprise worldwide, and the sole one in China, to successfully develop and commercialize solid-phase chip technology. This achievement effectively dismantles the long-standing monopoly previously held by U.S. firms in this domain. Solid-phase chips represent a critical 'bottleneck' technology within the agricultural sector. After five years of relentless research and development, bolstered by the support of the Ministry of Agriculture and Rural Affairs, among other entities, Lasso Biotechnology has achieved a significant breakthrough, marking a transition 'from 0 to 1' in this field, and has also formulated an initial solution.